1MacBcath G. Protein microarrays and proteomics. Nat Genet,2002,32:526-532.
2Wilson D, Nock S. Recent development in protein microarray technology, Angew Chem,2003,42:494-500.
3Robinson W,DiGennaro G, Hueber W,et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med, 2002,8 : 295-301.
4Emili AQ. Cagney G. Large scale functional analysis using peptide or protein arrays. Nature Biotechnology, 2000, 18:393-397.
5Weinberger SR, Dalmasso EA, Fung ET. Current achievements using protein chip array technology. Curr Opin Chem Biol, 2002,6: 86-91.
6Lin SR, Tseng FG, Huang HM, et al. Microsized protein arrays immobilized by microstamps and micro wells for disease diagnosis and drug screening. Fresenius J Anal Chem, 2001, 371:202- 208.
7Guzey C,spigset O. Genotyping of drug targets: a method to predict adverse drug reactions. Drug Saf,2002,25:553-560.
8Srinivas PR, Srivastava S, Hanash S,et al. proteomics in early detection of cancer. Clin Chem,2001,47:1901-1911.
9Bacarese-Hamiltom T, Ardizzoni A, Gray J, et al. Protein arrays for serodiagnosis of disease. Methods Mol Biol, 2004, 264:271-274.
1DINARELLO C A, POMERANTS B J. Proinflammatory cytokines in heart failure [J]. Blood Purrif, 2001,19:314-321.
2POUSSET F, ISNARD R, LECHAT P, et al. Prognostic value of plasma endothelin-linpatients with chronic heart failure[J]. Eur Heart J , 1997, 18:254-258.
3LOPPNOW H, WERDAN K, WERNER C. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed inpatients treated with β-adrenoceptor antagonist [J]. Auton Autacoid Pharmacol,2002 ,22:83-92.
4ABOU-RAYA S, NAIM A, MARZOUK S. Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases [J]. Clin Invest Med, 2004,27:93-100.
5KOTOWICZ K, DIXON G I, KLEIN N J, et al. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of kymphocyte[J]. Immunology, 2000, 100:441-444.
6UELAND T, AUKRUST P, YNDESTAD A, et al. Soluble CD40 ligand in acute and chronic heart failure[J]. Eur Heart J, 2005, 26:1101 - 1107.
7YIN W H, CHEN J W, JENA H L,et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure [J]. Eur J Heart Fail, 2003,5:507-516.
8HOBBS F D R, DAVIA R C, ROALFE A K, et al. Reliability of N-terminal probrain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community population [J]. BMJ,2002,324 : 1498-1498.
9GOTO T,TAKASE, H,TORIYAMA, T, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure[J]. Heart, 2003,89:1303-1307.
10Schweitzer B.Microarrays to characterize protein interactions on a wholeproteome scale.Proteomics,2003,3:2190-2199.
5Dua WD,Li W,Chena G,et al Detection of known base substitution mutations in human mitochondrial DNA of MERRF and MELAS by biochip technology. Biosensors and Bioelectronics, 2009,24 ( 8 ) : 2371-2376.
6Erali M, Schmidt B, Lyon E, et al. Evaluation of elect ronicmicroarrays for genotyping factor V, factor II, and MTHFR. Clin Chem, 2003,49:732-739.
7Los M,Los JM,Blohm L,et al. Rapid detection of viruses using electrical biochipsand anti-virion sera. Letters in Applied Microbiology,2005,40(6) :479-485.
8Yeung SW,Lee TMH ,Cai H ,Hsing IM. A DNA biochip for on-thespot multiplexed pathogen identification. Nucleic Acids Research, 2006,34(118) :1-7.
10Bartosiewicz M,Penn S, Buckpitt A. Applications of genearrays in environmental toxicology :fingerprints of gene regulation associated with cadmium chloride, benzo[ a] pyrene, and triehloroethylene. Environ Health Perspect ,2001,1 ( 1 ) :71-74.
